These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 25594860

  • 21. MicroRNAs related to androgen metabolism and polycystic ovary syndrome.
    Sørensen AE, Udesen PB, Wissing ML, Englund ALM, Dalgaard LT.
    Chem Biol Interact; 2016 Nov 25; 259(Pt A):8-16. PubMed ID: 27270454
    [Abstract] [Full Text] [Related]

  • 22. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymes.
    Xu ZH, Freimuth RR, Eckloff B, Wieben E, Weinshilboum RM.
    Pharmacogenetics; 2002 Jan 25; 12(1):11-21. PubMed ID: 11773860
    [Abstract] [Full Text] [Related]

  • 23. PAPSS2-related brachyolmia: Clinical and radiological phenotype in 18 new cases.
    Bownass L, Abbs S, Armstrong R, Baujat G, Behzadi G, Berentsen RD, Burren C, Calder A, Cormier-Daire V, Newbury-Ecob R, Foulds N, Juliusson PB, Kant SG, Lefroy H, Mehta SG, Merckoll E, Michot C, Monsell F, Offiah AC, Richards A, Rosendahl K, Rustad CF, Shears D, Tveten K, Wellesley D, Wordsworth P, Deciphering Developmental Disorders StudyWellcome Sanger Institute, Cambridge, UK., Smithson S.
    Am J Med Genet A; 2019 Sep 25; 179(9):1884-1894. PubMed ID: 31313512
    [Abstract] [Full Text] [Related]

  • 24. Bone Phenotype is Always Present But Androgen Excess is Less Frequently Seen in PAPSS2 Deficiency.
    Helvacıoğlu D, Güran T.
    J Clin Res Pediatr Endocrinol; 2024 Mar 11; 16(1):4-10. PubMed ID: 38084048
    [Abstract] [Full Text] [Related]

  • 25. 3'-Phosphoadenosine 5'-phosphosulfate (PAPS) synthases, naturally fragile enzymes specifically stabilized by nucleotide binding.
    van den Boom J, Heider D, Martin SR, Pastore A, Mueller JW.
    J Biol Chem; 2012 May 18; 287(21):17645-17655. PubMed ID: 22451673
    [Abstract] [Full Text] [Related]

  • 26. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization.
    Xu ZH, Otterness DM, Freimuth RR, Carlini EJ, Wood TC, Mitchell S, Moon E, Kim UJ, Xu JP, Siciliano MJ, Weinshilboum RM.
    Biochem Biophys Res Commun; 2000 Feb 16; 268(2):437-44. PubMed ID: 10679223
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Identification of sequence polymorphisms in two sulfation-related genes, PAPSS2 and SLC26A2, and an association analysis with knee osteoarthritis.
    Ikeda T, Mabuchi A, Fukuda A, Hiraoka H, Kawakami A, Yamamoto S, Machida H, Takatori Y, Kawaguchi H, Nakamura K, Ikegawa S.
    J Hum Genet; 2001 Feb 16; 46(9):538-43. PubMed ID: 11558903
    [Abstract] [Full Text] [Related]

  • 30. Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency.
    Weidler C, Struharova S, Schmidt M, Ugele B, Schölmerich J, Straub RH.
    Arthritis Rheum; 2005 Jun 16; 52(6):1721-9. PubMed ID: 15934093
    [Abstract] [Full Text] [Related]

  • 31. Human liver cytosolic sulfotransferase 2A1-dependent dehydroepiandrosterone sulfation assay by ultra-high performance liquid chromatography-tandem mass spectrometry.
    Bansal S, Lau AJ.
    J Pharm Biomed Anal; 2016 Feb 20; 120():261-9. PubMed ID: 26760244
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. SOX9 protein is stabilized by TGF-β and regulates PAPSS2 mRNA expression in chondrocytes.
    Chavez RD, Coricor G, Perez J, Seo HS, Serra R.
    Osteoarthritis Cartilage; 2017 Feb 20; 25(2):332-340. PubMed ID: 27746378
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of endocrine disruptors on dehydroepiandrosterone sulfotransferase and enzymes involved in PAPS synthesis: genomic and nongenomic pathways.
    Harris R, Turan N, Kirk C, Ramsden D, Waring R.
    Environ Health Perspect; 2007 Dec 20; 115 Suppl 1(Suppl 1):51-4. PubMed ID: 18174950
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.